common-pharma-interest benefits-of-medical-software-company-products 
pharmaphorum
MARCH 9, 2021
Nearly 70% of HCPs are now digital natives, with no interest in going back to pre-COVID sales engagement methods. To thrive in this environment, pharma needs to move from ad-hoc and reactionary digital transformation to long-term ‘digital excellence’, says Veeva’s Sebastien Noel.
pharmaphorum
NOVEMBER 25, 2021
With medical conferences and events long a mainstay for pharma-HCP interactions, the pandemic’s travel restrictions, and lockdowns forced these in-person meet-ups to go virtual. Before COVID, pharma events were mainly face-to-face. Rethinking pharma’s events’ strategy. The changing events model.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
APRIL 27, 2022
Before the COVID-19 pandemic, measuring engagement typically involved detailed follow-ups, contacting a pool of practitioners to gauge their awareness of a particular product and then extrapolating that information across the country. This is particularly evident in marketing. Redefining HCP engagement monitoring.
Drug Discovery World
SEPTEMBER 28, 2022
Its application in pharma, most commonly in drug discovery, has been steadily growing with global partnerships between tech vendors and pharma companies becoming more commonplace. According to Hampleton Patners’ latest Healthtech M&A market report2, digital health companies raised a total of $57.2
XTalks
OCTOBER 12, 2022
We [Philips Pharma Solutions, formerly BioTel Research] have successfully ran multi-site DCE-MRI trials,” said Edward Ashton, PhD, VP, Oncology Imaging, Philips Pharma Solutions. Magnetic resonance imaging (MRI) has had a part in clinical trials for more than three decades now.
Pharma Marketing Network
JUNE 8, 2020
Don (PMN): Hi good morning everyone, welcome to the pharma marketing podcast. I come to the pharma space from being a medical operator of clinics for the last 15 to 20 years where we took care of patients with specific disease conditions that were often overlooked. Bob and Mark thanks for joining us today.
pharmaphorum
AUGUST 16, 2021
Over the past two years, the pharma industry’s demand for automated research solutions has increased significantly and, particularly when it comes to clinical trial design, the need has never been greater. The length of time required for data mapping and conversions is another common challenge.
Expert insights. Personalized for you.
130 
Let's personalize your content